REGISTERED
on 14 Jun 2022
Last Applicant/ Owned by
Baarerstrasse 14
ZUG V8
CH
6300
Serial Number
88296694 filed on 11th Feb 2019
Registration Number
6760727 registered on 14th Jun 2022
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CTX110
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of can Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
First Use Date in General
22nd Jul 2019
First Use Date in Commerce
22nd Jul 2019
Class [005]
Pharmaceutical Products
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
First Use Date in General
22nd Jul 2019
First Use Date in Commerce
22nd Jul 2019
Mark Details
Serial Number
No 88296694
Mark Type
No Service Mark
Attorney Docket Number
No 33324/60002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Jun 2022 | REGISTERED-PRINCIPAL REGISTER |
| 14th Jun 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 10th May 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th May 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 27th Jan 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 27th Jan 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 12th Jan 2022 | TEAS STATEMENT OF USE RECEIVED |
| 12th Jan 2022 | USE AMENDMENT FILED |
| 16th Nov 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Nov 2021 | TEAS EXTENSION RECEIVED |